LRP5 and prostate cancer: Upstream factors of the Wnt pathway, such as Wnt ligands, Frizzled receptors, LRP5/6 co-receptors, exhibit specific alterations in expression within prostate cancer tissues, correlated with tumor differentiation, invasiveness, and prognosis [24].